TrialCell reports. Medicine2025

The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy.

David J Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.